Spm Pharma-Tech Private Limited - Due diligence report

A 360° intelligence report on Spm Pharma-Tech Private Limited: trust score, financial health, credit view, compliance, directors, growth and…

2019-04-25 Kalyan W, Maharashtra Active Unlisted
Share
Connect MCP
SP Spm Pharma-Tech Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Spm Pharma-Tech Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
82/100
Trust Score
Low Risk

Spm Pharma-Tech Private Limited is assessed as Low Risk with a Trust Score of 82/100. Spm Pharma-Tech Private Limited is an active private limited indian non-government company incorporated in 2019, operating in the Business Outsourcing sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 12 Aug 2026 from the latest processed filings. Spm Pharma-Tech Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
82/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 2 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Open charges exceed net worth - secured lenders rank ahead.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 1 open (73.96 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Others1 48.0 cr
Compliance Score: 75/100 Low Risk
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2021 - filings overdue.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
MANOJKUMAR DUBEY 01234567 Director 01/04/2018 6 yrs Approved
SUBHASH PARKHEY 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2021 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 70
Growth signals & trust indicators
Revenue acceleration: +38% over 1 year(s).
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
Operating for 7 years.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 61% in a year.
Statutory filings appear overdue.
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence76/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment73/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 73.96 Lakh already registered.
  • Compliance record supports lending.
Investor view90/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 6 events
31 Aug 2023
Charge created
Others - 73.96 Lakh
30 Nov 2021
Last AGM held
Annual general meeting
31 Mar 2021
Latest balance sheet
Filed with ROC
25 Apr 2019
Incorporated
Registered with Roc Mumbai Ii
Director appointed
MANOJKUMAR DUBEY (Director)
Director appointed
SUBHASH PARKHEY (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 38% over the last 1 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2021 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Alkin Global Technologies Private Limited U74999DL2019PTC347493 New Delhi, Delhi, India
Raa Media Private Limited U74300MH2004PTC149406 Mumbai, Maharashtra, India
Selsyn Infra Projects Private Limited U45400TG2015PTC100631 Secunderabad, Telangana, India
Caremate Facility Services Private Limited U74999PN2017PTC173281 Pune, Maharashtra, India
Myriad Softcorp Private Limited U72200MH2016PTC274103 Mumbai, Maharashtra, India
Agrimainfotech U72200KL2012PTC031716 Kolenchery, Kerala, India
Unified Business Web Solutions Private Limited U72900RJ2011PTC036718 Jaipur, Rajasthan, India
Spot Labs Private Limited U74110DL2015PTC275067 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Spm Pharma-Tech Private Limited before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Spm Pharma-Tech Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Spm Pharma-Tech Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether Spm Pharma-Tech Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Spm Pharma-Tech Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Spm Pharma-Tech Private Limited an active company?

Spm Pharma-Tech Private Limited has MCA status “Active” with a compliance score of 75/100 (Low Risk).

Is Spm Pharma-Tech Private Limited financially healthy?

Spm Pharma-Tech Private Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Spm Pharma-Tech Private Limited?

Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Spm Pharma-Tech Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Spm Pharma-Tech Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Spm Pharma-Tech Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2021 - filings overdue. Overall compliance score: 75/100 (Low Risk).

Is it risky to lend to Spm Pharma-Tech Private Limited?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.